Copyright © 2002 by the European Society of Cardiology.
Editorials
C-reactive protein and prognosis after percutaneous coronary intervention
Center for Cardiovascular Disease Prevention, Brigham and Women's Hospital, Boston, Massachusetts, U.S.A.
References
- Ross R. Atherosclerosisan inflammatory disease. N Engl J Med. 1999;340:115126
[Free Full Text] - de Winter RJ, Heyde GS, Koch KT. The prognostic value of pre-procedural plasma C-reactive protein in patients undergoing elective coronary angioplasty. Eur Heart J. 2002;23:960966
[Abstract/Free Full Text] - Bustos C, Hernandez-Presa MA, Ortego M. HMG-CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosis. J Am Coll Cardiol. 1998;32:20572064
[Abstract/Free Full Text] - Crisby M, Nordin-Fredriksson G, Shah PK, Yano J, Zhu J, Nilsson J. Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization. Circulation. 2001;103:926933
[Abstract/Free Full Text] - Fukumoto Y, Libby P, Rabkin E. Statins alter smooth muscle cell accumulation and collagen content in established atheroma of watanabe heritable hyperlipidemic rabbits. Circulation. 2001;103:993999
[Abstract/Free Full Text] - Ridker PM, Rifai N, Pfeffer MA, Sacks F, Braunwald E. Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators. Circulation. 1999;100:230235
[Abstract/Free Full Text] - Ridker PM, Rifai N, Lowenthal SP. Rapid reduction in C-reactive protein with cerivastatin among 785 patients with primary hypercholesterolemia. Circulation. 2001;103:11911193
[Abstract/Free Full Text] - Jialal I, Stein D, Balis D, Grundy SM, Adams-Huet B, Devaraj S. Effect of hydroxymethyl glutaryl coenzyme a reductase inhibitor therapy on high sensitive c-reactive protein levels. Circulation. 2001;103:19331935
[Abstract/Free Full Text] - Albert M, Danielson E, Rifai N, Ridker PM. Effect of statin therapy on C-reactive protein levels. The Pravastatin Inflammation/CRP Evaluation (PRINCE): a randomized trial and cohort study. JAMA. 2001;286:6470
[Abstract/Free Full Text] - Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000;342:836843
[Abstract/Free Full Text] - Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997;336:973979
[Abstract/Free Full Text] - Gaspardone A, Crea F, Versaci F. Predictive value of C-reactive protein after successful coronary-artery stenting in patients with stable angina. Am J Cardiol. 1998;82:515518[CrossRef][Web of Science][Medline]
- Gottsauner-Wolf M, Zasmeta G, Hornykewycz S. Plasma levels of C-reactive protein after coronary stent implantation. Eur Heart J. 2000;21:11521158
[Abstract/Free Full Text] - Chew DP, Bhatt DL, Robbins MA. Incremental prognostic value of elevated baseline C-reactive protein among established markers of risk in percutaneous coronary intervention. Circulation. 2001;104:992997
[Abstract/Free Full Text] - Heeschen C, Hamm CW, Bruemmer J, Simoons ML. Predictive value of C-reactive protein and troponin T in patients with unstable angina: a comparative analysis CAPTURE Investigators. Chimeric c7E3 AntiPlatelet Therapy in Unstable angina REfractory to standard treatment trial. J Am Coll Cardiol. 2000;35:15351542
[Abstract/Free Full Text] - Toss H, Lindahl B, Siegbahn A, Wallentin L. Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease. Circulation. 1997;96:42044210
[Abstract/Free Full Text] - Morrow DA, Rifai N, Antman EM. C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis in Myocardial Infarction. J Am Coll Cardiol. 1998;31:14601465
[Abstract/Free Full Text] - Lindahl B, Toss H, Siegbahn A, Venge P, Wallentin L. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease. N Engl J Med. 2000;343:11391147
[Abstract/Free Full Text] - Ridker PM, Rifai N, Clearfield M. Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. N Engl J Med. 2001;344:19591965
[Abstract/Free Full Text] - Liuzzo G, Buffon A, Biasucci LM. Enhanced inflammatory response to coronary angioplasty in patients with severe unstable angina. Circulation. 1998;98:23702376
[Abstract/Free Full Text] - Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA. 2001;286:327334
[Abstract/Free Full Text] - Ridker PM, Rifai N, Pfeffer MA. Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators. Circulation. 1998;98:839844
[Abstract/Free Full Text] - Ikonomidis I, Andreotti F, Economou E, Stefanadis C, Toutouzas P, Nihoyannopoulos P. Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin. Circulation. 1999;100:793798
[Abstract/Free Full Text] - Feldman M, Jialal I, Devaraj S, Cryer B. Effects of low-dose aspirin on serum C-reactive protein and thromboxane B2 concentrations: a placebo-controlled study using a highly sensitive C-reactive protein assay. J Am Coll Cardiol. 2001;37:20362041
[Abstract/Free Full Text] - Kennon S, Price CP, Mills PG. The effect of aspirin on C-reactive protein as a marker of risk in unstable angina. J Am Coll Cardiol. 2001;37:12661270
[Abstract/Free Full Text] - Danesh J, Whincup P, Walker M. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ. 2000;321:199204
[Abstract/Free Full Text] - Harris TB, Ferrucci L, Tracy RP. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med. 1999;106:506512[CrossRef][Web of Science][Medline]
- Koenig W, Sund M, Frohlich M. C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation. 1999;99:237242
[Abstract/Free Full Text] - Kuller LH, Tracy RP, Shaten J, Meilahn EN. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial. Am J Epidemiol. 1996;144:537547
[Abstract/Free Full Text] - Ridker PM, Buring JE, Shih J, Matais M, Hennekens CH. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation. 1998;98:731733
[Abstract/Free Full Text] - Tracy RP, Lemaitre RN, Psaty BM. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project. Arterioscler Thromb Vasc Biol. 1997;17:11211127
[Abstract/Free Full Text] - Anderson JL, Muhlestein JB, Horne BD. Plasma homocysteine predicts mortality independently of traditional risk factors and C-reactive protein in patients with angiographically defined coronary artery disease. Circulation. 2000;102:12271232
[Abstract/Free Full Text] - Liuzzo G, Biasucci LM, Gallimore JR. The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N Engl J Med. 1994;331:417424
[Abstract/Free Full Text] - Milazzo D, Biasucci LM, Luciani N. Elevated levels of C-reactive protein before coronary artery bypass grafting predict recurrence of ischemic events. Am J Cardiol. 1999;84:459461[CrossRef][Web of Science][Medline]
This article has been cited by other articles:
![]() |
S. Verma, P. E. Szmitko, and E. T.H. Yeh C-Reactive Protein: Structure Affects Function Circulation, April 27, 2004; 109(16): 1914 - 1917. [Full Text] [PDF] |
||||
![]() |
S. D. Wiviott, C. P. Cannon, D. A. Morrow, S. A. Murphy, C. M. Gibson, C. H. McCabe, M. S. Sabatine, N. Rifai, R. P. Giugliano, P. M. DiBattiste, et al. Differential Expression of Cardiac Biomarkers by Gender in Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction: A TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy-Thrombolysis In Myocardial Infarction 18) Substudy Circulation, February 10, 2004; 109(5): 580 - 586. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Biancari, J. Lahtinen, S. Lepojarvi, P. Rainio, E. Salmela, R. Pokela, M. Lepojarvi, J. Satta, and T. S. Juvonen Preoperative C-reactive protein and outcome after coronary artery bypass surgery Ann. Thorac. Surg., December 1, 2003; 76(6): 2007 - 2012. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-H. Wang, S.-H. Li, R. D. Weisel, P. W.M. Fedak, A. S. Dumont, P. Szmitko, R.-K. Li, D. A.G. Mickle, and S. Verma C-Reactive Protein Upregulates Angiotensin Type 1 Receptors in Vascular Smooth Muscle Circulation, April 8, 2003; 107(13): 1783 - 1790. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Cipollone and C. Patrono Cyclooxygenase-2 Polymorphism: Putting a Brake on the Inflammatory Response to Vascular Injury? Arterioscler Thromb Vasc Biol, October 1, 2002; 22(10): 1516 - 1518. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||


